All In MedTech

FDA Clearance Tracker · P030039-S024

Coseal Surgical Sealant, Coseal Spray Set, Coseal Replacement Applicator, Coseal Extended Applicator

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 14, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 14, 2020

Approved

Time to decision

805 days

Received Jun 1, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P030039-S024
Device name
Coseal Surgical Sealant, Coseal Spray Set, Coseal Replacement Applicator, Coseal Extended Applicator
Applicant location
Round Lake,, IL
Received
Jun 1, 2018
Decided
Aug 14, 2020
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P030039

Device type

Device class
Class III

Every decision under product code NBE

FDA's approval statement

As written in FDA's record.

Approval for a design change to the applicator and changes to the manufacturing site and labeling to reflect the updated applicator.

Source documents

Other decisions for Baxter Bio Science

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.